Production (Stage)
Lisata Therapeutics, Inc.
LSTA
$2.69
$0.041.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.53% | 14.07% | 6.29% | -25.25% | 12.70% |
| Total Depreciation and Amortization | -6.52% | -12.77% | -10.64% | -4.26% | -4.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.64% | 150.45% | 1,008.33% | -67.90% | -21.33% |
| Change in Net Operating Assets | 41.66% | -150.15% | 30.93% | 26.52% | 19.24% |
| Cash from Operations | 23.13% | -11.28% | 29.72% | -26.27% | 14.26% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 46.97% | 124.31% | -151.46% | 1,715.59% | 50.06% |
| Cash from Investing | 46.54% | 124.31% | -151.46% | 1,715.59% | 50.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 50.00% | -- | -92.92% | -- |
| Repurchase of Common Stock | -71.13% | -- | 100.00% | -- | -67.06% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 83.80% | -500.00% | 100.00% | -92.92% | -67.06% |
| Foreign Exchange rate Adjustments | 103.64% | 14.47% | -48.00% | 425.00% | -685.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 608.63% | 66.45% | -200.53% | 245.31% | 80.30% |